Current Opinion on Therapeutic Patents

Titel Veröffentlichungsdatum Sprache Zitate
Patent Evaluation: The Use of Spider Toxins for the Treatment of Neurodegenerative Disease1992/12/01English
Patent Update: A Review of Recent Hypolipidaemic Patents1992/07/01English
Patent News1992/07/01English
Patent News1992/09/01English
Patent Evaluation: A New Growth Hormone Stimulator1992/09/01English
Patent Evaluation: Dimeric Vinca Alkaloids that Reverse MDR1992/01/01English
Patent Update: Antibacterial Patents Appearing in the Fourth Quarter of 19911992/03/01English
Patent Evaluation: C-KIT Ligand Receptor1992/07/01English
Patent News1992/09/01English
Patent Evaluation: Nuclease Resistant Antisense Oligonucleotides1992/07/01English
Patent News1992/03/01English
Patent Evaluation: Treatment and Diagnosis of Chronic Fatigue Immunodysfunction Syndrome1992/07/01English
Patent Evaluation: Novel class III anti-arrhythmics1992/03/01English
Patent Evaluation: A Stable Expression Vector forE. coli1992/12/01English
Overview: Cardiovascular Therapy Involving β-Adrenoceptor Partial Agonists1992/01/01English
Overview: High Efficiency Oligonucleotide-Directed Mutagenesis of Double-stranded DNA Vectors1992/07/01English
Patent Evaluation: Highly potent 5-lipoxygenase inhibitors containing a tetrahydropyranyl moiety1992/03/01English
Immunoassays and Reagents: December to February1992/03/01English
Patent Evaluation: Molecular mechanisms involved in glioblastoma formation1992/02/01English
Patent Evaluation: Azabicycles as ACh Agonists1992/07/01English
Patent News1992/09/01English
Anxiolytic Patents - April to June 19921992/07/01English
Patent News1992/02/01English
Patent News1992/03/01English
Patent News1992/09/01English
Patent Evaluation: Hydroxamic Acid 5-Lipoxygenase Inhibitors1992/09/01English
Patent Evaluation: Indolalkylamine derivatives as 5-HT2antagonists1992/03/01English
Patent Evaluation: Prostaglandin Synthesis Inhibitors in Foam Formulations1992/12/01English
Patent Evaluation: Indole Derivatives which Inhibit Leukotriene Biosynthesis1992/07/01English
Patent Evaluation: Novel 3-Indolyl Thioacetate Derivatives as NMDA Receptor Antagonists1992/01/01English